View in EDS

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

Saved in:
Bibliographic Details
Title: TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
Authors: Sarkar D; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Gyanwali GC; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Patel J; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand., Shevchuk P; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Jeffs A; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand., Woolley AG; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Wang S; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Sardari M; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Bhandarkar A; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Siddiqui H; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Ratajska M; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Division of Pathology and Neuropathology, Medical University of Gdansk, Gdansk, Poland., Sarwar M; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand., Kannan S; Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Verma CS; Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Drummond CJ; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., McKinney C; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand., Antony J; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand., McCormick SP; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Braithwaite A; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand., Mehta S; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand. sunali.mehta@otago.ac.nz.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand. sunali.mehta@otago.ac.nz.
Source: Cancer gene therapy [Cancer Gene Ther] 2026 Jun 05. Date of Electronic Publication: 2026 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42249018
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sarkar+D%22">Sarkar D</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Gyanwali+GC%22">Gyanwali GC</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Patel+J%22">Patel J</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Shevchuk+P%22">Shevchuk P</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Jeffs+A%22">Jeffs A</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Woolley+AG%22">Woolley AG</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sardari+M%22">Sardari M</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Bhandarkar+A%22">Bhandarkar A</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Siddiqui+H%22">Siddiqui H</searchLink>; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Ratajska+M%22">Ratajska M</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Division of Pathology and Neuropathology, Medical University of Gdansk, Gdansk, Poland.<br /><searchLink fieldCode="AU" term="%22Sarwar+M%22">Sarwar M</searchLink>; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Kannan+S%22">Kannan S</searchLink>; Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Verma+CS%22">Verma CS</searchLink>; Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Drummond+CJ%22">Drummond CJ</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22McKinney+C%22">McKinney C</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Antony+J%22">Antony J</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22McCormick+SP%22">McCormick SP</searchLink>; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Braithwaite+A%22">Braithwaite A</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mehta+S%22">Mehta S</searchLink>; Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand. sunali.mehta@otago.ac.nz.; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand. sunali.mehta@otago.ac.nz.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2026 Jun 05. <i>Date of Electronic Publication: </i>2026 Jun 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42249018
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41417-026-01045-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sarkar D
      – PersonEntity:
          Name:
            NameFull: Gyanwali GC
      – PersonEntity:
          Name:
            NameFull: Patel J
      – PersonEntity:
          Name:
            NameFull: Shevchuk P
      – PersonEntity:
          Name:
            NameFull: Jeffs A
      – PersonEntity:
          Name:
            NameFull: Woolley AG
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Sardari M
      – PersonEntity:
          Name:
            NameFull: Bhandarkar A
      – PersonEntity:
          Name:
            NameFull: Siddiqui H
      – PersonEntity:
          Name:
            NameFull: Ratajska M
      – PersonEntity:
          Name:
            NameFull: Sarwar M
      – PersonEntity:
          Name:
            NameFull: Kannan S
      – PersonEntity:
          Name:
            NameFull: Verma CS
      – PersonEntity:
          Name:
            NameFull: Drummond CJ
      – PersonEntity:
          Name:
            NameFull: McKinney C
      – PersonEntity:
          Name:
            NameFull: Antony J
      – PersonEntity:
          Name:
            NameFull: McCormick SP
      – PersonEntity:
          Name:
            NameFull: Braithwaite A
      – PersonEntity:
          Name:
            NameFull: Mehta S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 06
              Text: 2026 Jun 05
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5500
          Titles:
            – TitleFull: Cancer gene therapy
              Type: main
ResultId 1